Penile cancer: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
A. Muneer, Marco Bandini, Éva Compérat, Gert De Meerleer, Karim Fizazi, Jourik A. Gietema, Silke Gillessen, Alex Kirkham, Vijay Sangar, Constantine Alifrangis, Tom Powles
Abstract
Penile cancer is a rare genital malignancy with an estimated global incidence of 36 068 new cases in 2020.1 In Western Europe and the United States, the age-adjusted incidence of penile cancer is 0.3-2.1 per 100 000.2 Conversely, in countries where circumcision is routine practice due to religious or cultural reasons,3 penile cancer is almost non-existent, whereas areas within South America, South Asia and Sub-Saharan Africa have the highest prevalence in the world (3-7 per 100 000 men).1,4
Topics & Concepts
GuidelineMedicineCancerClinical PracticePenile cancerOncologyInternal medicineFamily medicinePathologyGenital Health and DiseaseUrologic and reproductive health conditionsUrological Disorders and Treatments